Mixed connective tissue disease historical perspective
|
Mixed connective tissue disease Microchapters |
|
Differentiating Mixed connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mixed connective tissue disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Mixed connective tissue disease historical perspective |
|
FDA on Mixed connective tissue disease historical perspective |
|
Mixed connective tissue disease historical perspective in the news |
|
Blogs onMixed connective tissue disease historical perspective |
|
Directions to Hospitals Treating Mixed connective tissue disease |
|
Risk calculators and risk factors for Mixed connective tissue disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Historical Perspective
- MCTD was first defined by Gordon C.Sharp et al., in 1972.
- MCTD has been the first rheumatic disease syndrome defined by a serologic test (positive U1RNP).[1][2]
- In 1976, Alarcon-Segovia proposed criteria for classifying mixed connective tissue disease among all types of connective tissue diseases. It demonstrates the close association between MCTD and Sjogren's syndrome.[3]
References
- ↑ Vij M, Agrawal V, Jain M (July 2014). "Scleroderma renal crisis in a case of mixed connective tissue disease". Saudi J Kidney Dis Transpl. 25 (4): 844–8. PMID 24969199.
- ↑ Hoffman RW, Maldonado ME (July 2008). "Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review". Clin. Immunol. 128 (1): 8–17. doi:10.1016/j.clim.2008.03.461. PMID 18439877.
- ↑ Alarcón-Segovia D (October 1984). "Symptomatic Sjögren's syndrome in mixed connective tissue disease". J. Rheumatol. 11 (5): 582–3. PMID 6512789.